Characteristics of COVID-19 disease in multiple sclerosis patients

被引：21
作者：
Barzegar, Mahdi [1 ,2 ]
Mirmosayyeb, Omid [1 ,2 ,3 ]
Ghajarzadeh, Mahsa [3 ]
Nehzat, Nasim [1 ,3 ]
Vaheb, Saeed [1 ]
Shaygannejad, Vahid [1 ,2 ]
Vosoughi, Reza [4 ]
机构：
[1] Isfahan Univ Med Sci, Isfahan Neurosci Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Sch Med, Dept Neurol, Esfahan, Iran
[3] Univ Tehran Med Sci, Universal Council Epidemiol UCE, Univ Sci Educ & Res Network USERN, Tehran, Iran
[4] Univ Toronto, St Michaels Hosp, Multiple Sclerosis Clin, Toronto, ON, Canada
来源：
MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 45卷
关键词：
D O I：
10.1016/j.msard.2020.102276
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 11 条
[1]   COVID-19 infection in a patient with multiple sclerosis treated with fingolimod [J].
Barzegar, Mahdi ;
Mirmosayyeb, Omid ;
Nehzat, Nasim ;
Sarrafi, Reza ;
Khorvash, Farzin ;
Maghzi, Amir-Hadi ;
Shaygannejad, Vahid .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (04)
[2]   Severe COVID-19 infection in a patient with multiple sclerosis treated with fi ngolimod [J].
Foerch, Christian ;
Friedauer, Lucie ;
Bauer, Boris ;
Wolf, Timo ;
Adam, Elisabeth H. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
[3]   Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic [J].
Ghajarzadeh, Mahsa ;
Mirmosayyeb, Omid ;
Barzegar, Mahdi ;
Nehzat, Nasim ;
Vaheb, Saeed ;
Shaygannejad, Vahid ;
Maghzi, Amir-Hadi .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
[4]   Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis [J].
Mirmosayyeb, Omid ;
Brand, Serge ;
Barzegar, Mahdi ;
Afshari-Safavi, Alireza ;
Nehzat, Nasim ;
Shaygannejad, Vahid ;
Bahmani, Dena Sadeghi .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (05)
[5]   Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain [J].
Montero-Escribano, Paloma ;
Matias-Guiu, Jorge ;
Gomez-Iglesias, Patricia ;
Porta-Etessam, Jesus ;
Pytel, Vanesa ;
Matias-Guiu, Jordi A. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
[6]   COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role? [J].
Novi, Giovanni ;
Mikulska, Malgorzata ;
Briano, Federica ;
Toscanini, Federica ;
Tazza, Francesco ;
Uccelli, Antonio ;
Inglese, Matilde .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
[7]   Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [J].
Richardson, Safiya ;
Hirsch, Jamie S. ;
Narasimhan, Mangala ;
Crawford, James M. ;
McGinn, Thomas ;
Davidson, Karina W. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20) :2052-2059
[8]   Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? [J].
Ritchie, Andrew I. ;
Singanayagam, Aran .
LANCET, 2020, 395 (10230) :1111-1111
[9]   B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran [J].
Safavi, Farinaz ;
Nourbakhsh, Bardia ;
Azimi, Amir Reza .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 43
[10]   An Italian programme for COVID-19 infection in multiple sclerosis [J].
Sormani, Maria Pia .
LANCET NEUROLOGY, 2020, 19 (06) :481-482
12